Skip to content

A Clinical Randomized Controlled Trial of 'Tiao Shen Tong Du' Acupuncture Combined with Precise Transcranial Magnetic Stimulation for Motor Disorders in Progressive Supranuclear Palsy.

A Clinical Randomized Controlled Trial of 'Tiao Shen Tong Du' Acupuncture Combined with Precise Transcranial Magnetic Stimulation for Motor Disorders in Progressive Supranuclear Palsy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000281
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-04
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progressive Supranuclear Palsy

Interventions

Experimental group and control group:Acupuncture combined with transcranial magnetic stimulation
Control Group:Transcranial Magnetic Stimulation Combined with Sham Acupuncture

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age between 40 and 85 years; 2. Clinical symptoms, signs, and electrophysiological examinations suggest Progressive Supranuclear Palsy (PSP); according to the updated PSP diagnostic criteria published by the Movement Disorder Society (MDS) PSP Working Group in 2017, probable or possible PSP, including all subtypes with postural instability in the clinical pull test; 3. Presence of lower limb motor dysfunction, including but not limited to increased muscle tone, balance disorders, and abnormal posture and gait; 4. During the study period, maintain stable and unchanged drug treatment doses, such as cholinergic, dopaminergic, 5-hydroxytryptamine (serotonin)ergic, or NMDA receptor antagonists.

Exclusion criteria

Exclusion criteria: 1. History of epilepsy or a history of epilepsy in first-degree relatives; 2. Individuals with cardiac pacemakers, cochlear implants, or other metallic foreign bodies, or any implanted electronic devices, or those with claustrophobia or other contraindications for MRI scans or TMS therapy; 3. Participants who have received TMS, transcranial electrical stimulation, transcranial focused ultrasound, or other neuroregulation therapies within the past three months; 4. Coagulation disorders; 5. Severe infection, ulcers, or tumor infiltration at the acupuncture site; 6. Unable to comply with follow-up due to regional or other reasons.

Design outcomes

Primary

MeasureTime frame
Progressive Supranuclear Palsy Rating Scale;

Secondary

MeasureTime frame
Traditional Chinese Medicine (TCM) Syndrome Scale;Berg Balance Scale;Timed Up and Go Test;10-Meter Walk Test;Fall Index;Gait Analysis;Modified Ashworth Scale;

Countries

China

Contacts

Public ContactZhang Na

Peking University Third Hospital

letian506@163.com13581653384

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026